| Pharmaceuticals | Animal health formulations including injectable and nutritional products for farm and companion animals. | EUGMP approved manufacturing, extensive R&D, strategic market presence, and growing partnerships including exclusive distribution agreements. | B2B customers including veterinary pharma companies, distributors, and farm owners globally. | Injectables and specialized nutritional bio-active products. | 1782 | 70 | Product sales through direct field force and distributors in regulated and emerging markets. | Direct sales and long-term contracts with distributors; competitive pricing with cost reduction initiatives. | Geographic expansion in India, Europe, and Americas, new product launches, regulatory approvals, and companion animal market growth. | Phyto-solutions, Tulaject (Tuathromycin injectable), Anesthetics |
| Analytical Services and APIs | API manufacturing, contract development and manufacturing operations (CDMO), analytical testing services. | Network of 10 globally approved manufacturing plants, advanced R&D labs, strong regulatory compliance, and backward integration. | Pharmaceutical companies globally including human and animal health sectors. | Complex APIs and contract manufacturing services. | 750 | 30 | Sales of APIs, contract manufacturing services, and analytical testing contracts. | Contractual sales, usage-based manufacturing fees, and recurring service agreements. | Patent cliff API opportunities, CDMO market expansion, cost optimization, and increased base of regulated market filings. | Manufactured APIs with multiple global regulatory certifications including USFDA, EDQM; Analytical labs as support service |
